FDA official logo
GSRS logoPFDA official logo

ELASOMERAN

UNII:EPK39PL4R4
Formula:
Preferred Substance Name:ELASOMERAN

  • 2430046-03-8
  • CX-024414
  • ELASOMERAN [INN]
  • ELASOMERAN [JAN]
  • ELASOMERAN [WHO-DD]
  • M-1273
  • MESSENGER RNA (MRNA), 5'-CAPPED, ENCODING A FULL-LENGTH, CODONOPTIMISED PRE-FUSION STABILISED CONFORMATION VARIANT (K986P AND V987P) OF THE SARS-COV-2 (SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; GENBANK ID MN908947.3) SPIKE (S) GLYCOPROTEIN, FURTHER OPTIMIZED BY TWO ADDITIONAL STOP CODONS, FLANKED BY AN ARTIFICIAL 5' UNTRANSLATED REGION (UTR) AND A 3' UTR DERIVED FROM THE HUMAN ALPHA GLOBIN GENE (HBA1) AND TERMINATED BY A 3' POLY(A) TAIL; CONTAINS N1-METHYLPSEUDOURIDINE INSTEAD OF URIDINE (ALL-U>M1.PSI.)
  • MODERNA COVID-19 VACCINE RNA
  • MRNA-1273
  • MRNA-BASED VACCINE ENCODING A PRE-FUSION STABILIZED SPIKE PROTEIN FROM THE 2019-NOVEL CORONAVIRUS (2019-NCOV)
  • RNA (RECOMBINANT 5'-(M7G-(5'->5')-PPP-GM)-CAPPED ALL URIDINE->N1-METHYLPSEUDOURIDINE-SUBSTITUTED SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 PRE-FUSION SPIKE GLYCOPROTEIN (986-PROLINE,987-PROLINE)-SPECIFYING POLY(A)-TAILED MESSENGER CX-024414), INNER SALT
  • SPIKEVAX MRNA
  • TAK-919



UNII - EPK39PL4R4 | UNII Search Service